What if you could outsmart a highly trained Black Belt without relying on size, speed, or brute strength? In this video, ...

The U.S. and its allies are accelerating pipelines, export terminals, and overland trade corridors to reduce global ...

After controlling for factor exposures, sustainability-focused portfolios retained stronger ESG characteristics while delivering performance broadly in line with their regional benchmarks.

Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization to expand the approved indication for Hympavzi (marstacimab) to include patients 12 years of age and older ...

Pfizer Inc. (NYSE: PFE)today announced that the European Commission (EC) has granted marketing authorization to expand the approved indication for HYMPAVZI ® (marstacimab) to include patients 12 years ...

Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization to expand the approved indication for HYMPAVZI® (marstacimab) to include patients 12 years ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Hympavzi is FDA-approved to treat hemophilia A and B in patients ages 12 and older who do not have ...

Expanded population under review: The FDA granted priority review to marstacimab for patients 6 years and older with hemophilia A or B with inhibitors and for children aged 6 to 11 years without ...

When investors think about risk in equity portfolios, the usual suspects come to mind - market risk, sector risk or maybe even macroeconomic risk. In today’s rapidly shifting markets, such unintended ...